Literature DB >> 11279185

CD95 signaling via ceramide-rich membrane rafts.

H Grassme1, A Jekle, A Riehle, H Schwarz, J Berger, K Sandhoff, R Kolesnick, E Gulbins.   

Abstract

Clustering seems to be employed by many receptors for transmembrane signaling. Here, we show that acid sphingomyelinase (ASM)-released ceramide is essential for clustering of CD95. In vitro and in vivo, extracellularly orientated ceramide, released upon CD95-triggered translocation of ASM to the plasma membrane outer surface, enabled clustering of CD95 in sphingolipid-rich membrane rafts and apoptosis induction. Whereas ASM deficiency, destruction of rafts, or neutralization of surface ceramide prevented CD95 clustering and apoptosis, natural ceramide only rescued ASM-deficient cells. The data suggest CD95-mediated clustering by ceramide is prerequisite for signaling and death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279185     DOI: 10.1074/jbc.M101207200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  184 in total

1.  Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.

Authors:  Eric Norman; Roy G Cutler; Richard Flannery; Yue Wang; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

Review 2.  Ion channels and membrane rafts in apoptosis.

Authors:  I Szabò; C Adams; E Gulbins
Journal:  Pflugers Arch       Date:  2004-04-08       Impact factor: 3.657

3.  Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.

Authors:  Isabell Lang; Andrea Fick; Viktoria Schäfer; Tina Giner; Daniela Siegmund; Harald Wajant
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis.

Authors:  Glady Hazitha Samuel; Stefania Lenna; Andreea M Bujor; Robert Lafyatis; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2012-06-26       Impact factor: 4.563

Review 5.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

6.  Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts).

Authors:  Peter Sawatzki; Thomas Kolter; Robert Bittman; Erwin London
Journal:  Biochim Biophys Acta       Date:  2007-05-13

7.  The phenyltetraene lysophospholipid analog PTE-ET-18-OMe as a fluorescent anisotropy probe of liquid ordered membrane domains (lipid rafts) and ceramide-rich membrane domains.

Authors:  Omar Bakht; Javier Delgado; Francisco Amat-Guerri; A Ulises Acuña; Erwin London
Journal:  Biochim Biophys Acta       Date:  2007-05-13

Review 8.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

9.  Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.

Authors:  Jurgen Bock; Gerhard Liebisch; Joachim Schweimer; Gerd Schmitz; Gerhard Rogler
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

10.  Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Authors:  Sahra Bodo; Cécile Campagne; Tin Htwe Thin; Daniel S Higginson; H Alberto Vargas; Guoqiang Hua; John D Fuller; Ellen Ackerstaff; James Russell; Zhigang Zhang; Stefan Klingler; HyungJoon Cho; Matthew G Kaag; Yousef Mazaheri; Andreas Rimner; Katia Manova-Todorova; Boris Epel; Joan Zatcky; Cristian R Cleary; Shyam S Rao; Yoshiya Yamada; Michael J Zelefsky; Howard J Halpern; Jason A Koutcher; Carlos Cordon-Cardo; Carlo Greco; Adriana Haimovitz-Friedman; Evis Sala; Simon N Powell; Richard Kolesnick; Zvi Fuks
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.